Table 4.
Univariate and multivariate analyses of factors associated with nonalcoholic fatty liver disease (NAFLD).
| Variables | Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p | OR | 95% CI | p | |
| Gender | 1.485 | 0.983–2.243 | 0.060 | |||
| Age | 0.982 | 0.967–0.997 | 0.016 | 0.973 | 0.953–0.993 | 0.008 |
| SBP | 1.028 | 1.016–1.041 | <0.001 | |||
| DBP | 1.052 | 1.033–1.071 | <0.001 | |||
| Hyperuricemia | 1.447 | 0.972–2.154 | 0.069 | |||
| Hyperlipidemia | 1.521 | 1.017–2.275 | 0.041 | |||
| T2DM | 1.066 | 0.651–1.746 | 0.800 | |||
| Alcohol consumption | 1.897 | 1.313–2.741 | 0.001 | |||
| Smoking | 1.136 | 0.778–1.660 | 0.509 | |||
| ALT | 0.999 | 0.995–1.002 | 0.473 | |||
| AST | 1.001 | 0.996–1.006 | 0.685 | |||
| GGT | 1.008 | 1.003–1.013 | 0.001 | 1.008 | 1.002–1.014 | 0.010 |
| PLT | 1.001 | 0.998–1.004 | 0.567 | |||
| WHR (<0.9 vs ≥0.9) | 4.669 | 3.154–6.910 | <0.001 | 3.148 | 1.918–5.164 | <0.001 |
| BMI (<28 vs ≥28) | 10.950 | 7.376–16.257 | <0.001 | 7.417 | 4.547–12.099 | <0.001 |
| HBV DNA | 0.999 | 0.904–1.104 | 0.987 | |||
| HBeAg status | 1.107 | 0.780–1.570 | 0.570 | |||
ALT: serum aspartate aminotransferase; AST: alanine aminotransferase; BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; GGT: gamma-glutamyltransferase; HBeAg: hepatitis B e antigen; HBV: hepatitis B virus; OR: odds ratio; PLT: platelet; SBP: systolic blood pressure; T2DM: type 2 diabetes mellitus; WHR: waist-hip ratio.